Malin in valuation fall amid Poseida sale, EUR150 million return
(Alliance News) - Malin Corp PLC on Wednesday reported a valuation decline over the first half of 2025, but hailed the sale of its Poseida Therapeutics Inc stake as a "very significant milestone". Read More